NCT06102863View on ClinicalTrials.gov

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

PHASE2RecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

August 1, 2025

Study Completion Date

September 1, 2025

Conditions
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
Interventions
DRUG

statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);

Progesterone regimen (oral medroxyprogesterone acetate tablet 250mg-500mg/ day or Mirena +GnRHa3.75mg subcutaneous injection monthly) combined with statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);

Trial Locations (1)

100044

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors
collaborator

Beihang University

OTHER

collaborator

Peking University

OTHER

lead

Peking University People's Hospital

OTHER